Vista Group, Global Leader in Film Industry Software, Unveils Latest Innovations at CineEurope 2018
Vista Group International (NZX & ASX: VGL), the world’s leading provider of software solutions for the film industry, will be showcasing a host of innovations and thought leaders at CineEurope 2018 from June 11-14 in Barcelona, Spain.
Cinema Manager is Vista Cinema’s first major software release toward making our cinema management suite of products cloud-ready. See for yourself at Booth #101 why Cinema Manager has received stunning feedback on its new intuitive user interface which enables a cinema manager’s common tasks to be completed in less time and with fewer risk of errors.
From the Vista Apps portfolio, enhancements to Vista Mobile enable moviegoers to satisfy their F&B cravings without leaving the auditorium. Leveraging Vista’s moviegoer app (Mobile), and staff app (InTouch), new functionality creates an integrated workflow between the two. Guests request assistance from their seat with Vista Mobile, and staff responds with InTouch to resolve their enquiries.
Cinema Intelligence , the leader in business intelligence solutions, comes to CinemaCon with three major advances. Film Manager (FM), in collaboration with Vista Cinema, provides customers with optimized booking, scheduling and analytics capabilities. Advanced Booking optimizes the booking and content planning process with an advanced and intelligent tool that empowers cinema exhibitors to make the best decisions based on past performance, forecasting information and “what-if” analysis. Opus Data integration allows customers to access domestic Box Office performance directly in Cinema Intelligence, removing the need to chase information on multiple industry specific sites.
Veezi , Vista’s cloud-based cinema management solution for independent cinemas, which will exhibit at Booth #107, continues its extraordinary march across the U.S. independents sector and in Europe has secured customers in Spain, France, Sweden and Finland.
MovieXchange (MX) is Vista Group’s new web platform designed to streamline historically disparate and inefficient movie industry processes. Via MX products MX Film, MX Showtimes and MX Tickets, the product enables the sharing of distributor-supplied promotional movie materials essential to exhibitors, the central availability of global (and marketable) cinema show-time data, and a single source that ticket sellers can connect to and transact against all exhibitors. Additional to the accrued benefits to distributors, exhibitors and ticketing vendors, movieXchange enables a range of streamlined options for moviegoers to choose their movie and book their seat. Tickets are selling fast and volumes increasing weekly via the movieXchange platform.
Powster will be showcasing three new product innovations in the main foyer (CI Booth 26). After successful Beta testing, Powster Full Ticketing is live. The Powster ticketing model, in part related to movieXchange’s MX Ticket Service (Vista’s new global ticketing platform), is unique to the industry. Payments are deposited directly to the cinema's merchant account, eliminating previous administrative hang-ups. For studios, Powster full ticketing ensures visibility and measurement of the entire purchasing process culminating in actual ticket sales and helping the studio to sell more tickets at the cinema.
Facebook research shows 50% of group conversations on Messenger talk about movies. Powster’s Movies on Messenger allows cinemagoers to purchase movie tickets and organize groups of friends directly within Facebook Messenger. Augmented reality movie posters will be showcased on the Powster screen using Warner Brothers’ The Meg and Paramount’s Mission Impossible: Fallout as demonstrations. Moviegoers can now scan posters to see showtimes, watch the trailer, or interact with a custom-built AR experience.
Vista Group Panelists:
Mischa Kay, Vista Entertainment Solutions (‘Vista Cinema’) Managing Director, EMEA, will participate in the panel: “Software Analytics & Digital Marketing in Cinema” on Tuesday, June 12th from 11:30am to 1:30pm. (Exhibition Hall, Level 0)
Gabriel Swartland, Head of Client Services, EMEA, for Movio, will be a panelist for “Jump-Starting Event Cinema” Thursday, June 14th at 1:45pm to 2:45pm. (Exhibition Hall, Level 0)
Visit Vista at:
Vista Group Booth 101
Veezi Booth 107
Powster in CI Booth 206
About Vista Group International:
Vista Group International (Vista Group) is a public company, listed on
both the New Zealand and Australian stock exchanges (NZX & ASX: VGL).
The Group provides software and additional technology solutions across
the global film industry. Cinema management software is provided by
Vista Entertainment Solutions (‘Vista Cinema’), the core business of the
Group. Movio (authority in moviegoer data analytics), Veezi (cloud-based
SaaS software for the Independent Cinema Market), movieXchange
(connecting the movie industry to simplify the promotion and sale of
movie tickets), Maccs (film distribution software), Numero (box office
reporting software for film distributors and cinemas), Cinema
Intelligence (business intelligence solutions), Powster (creative studio
and marketing platform for movie studios) and Flicks (moviegoer ‘go to’
portal for movie information) provide an innovative range of
complementary products across additional film industry sectors, from
production and distribution, to cinema exhibition through to the
moviegoer experience. Vista Group has offices located in New Zealand
(Auckland HQ), Sydney, Los Angeles, London, Shanghai, Beijing, Mexico
City, South Africa, the Netherlands and Romania.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza16.8.2018 05:00 | Pressemelding
BioNTech AG, a rapidly growing biotechnology company focused on precise immunotherapies for the treatment of cancer and infectious disease, today announced that it has entered into a multi-year research and development (R&D) collaboration with Pfizer Inc. (NYSE: PFE) to develop mRNA-based vaccines for prevention of influenza (flu). Under the terms of the agreement, BioNTech and Pfizer will jointly conduct research and development activities to help advance mRNA-based flu vaccines. Pfizer will assume sole responsibility for further clinical development and commercialization of mRNA-based flu vaccines, following BioNTech’s completion of a first in human clinical study. BioNTech will receive $120 million in upfront, equity and near-term research payments and up to an additional $305 million in potential development, regulatory and commercial milestone payments. In addition, BioNTech will receive up to double-digit tiered royalty payments associated with worldwide sales if the program reac
Maxion Wheels to Showcase Market-Leading Light Weight Commercial Vehicle Wheels at REIFEN 201816.8.2018 04:05 | Pressemelding
Maxion Wheels, the world’s largest producer of wheels, announced today its participation in REIFEN, the leading tire and wheel industry event in Europe, from Sept. 11 – 15, 2018 in Hall 12.1 / Stand D24. For the first time, REIFEN will be co-located with Automechanika Frankfurt at the Messe Frankfurt. “REIFEN is the premier event for European tire and wheel manufacturers and resellers, bringing us together to meet and collaborate on the important aftermarket themes of innovation, service and delivery,” stated Mark Gerardts, Vice President of Global Sales and Marketing, Maxion Wheels. “After a highly popular launch to truck and trailer OEMs in 2017, we’re excited to have the industry’s lightest mass production steel wheel now available to our aftermarket distributors. This wheel, along with several others, including our new 10.00W-20 wide base tubetype and tubeless heavy duty armored vehicles wheel are great examples of our continued efforts to bring our OE multi-application innovations
Lenovo Accelerates Turnaround with Back-to-Back, Double-Digit Quarterly Revenue Growth15.8.2018 23:40 | Pressemelding
Lenovo Group (HKSE: 0992) (PINK SHEETS: LNVGY) today announced results for its first fiscal quarter ended June 30, 2018. For the second straight quarter, Lenovo achieved strong double-digit growth in revenue year-on-year. Group revenue reached US$11.91 billion, up 19% year-on-year. The company also reported strong pre-tax income during the quarter of US$113 million, an improvement of US$182 million year-on-year, as profitability improved across all businesses. In the first fiscal quarter, Lenovo’s profit attributable to equity holders grew to US$77 million, up US$149 million year-over-year. Basic earnings per share in the first fiscal quarter was 0.65 US cents or 5.10 HK cents. “As we persistently execute our 3-wave strategy, all our businesses made solid improvements in both revenue and profitability. Lenovo has passed the turning point and entered a phase of ‘acceleration’ - accelerating the execution of our transformation strategy and accelerating the rising momentum in business per
CORRECTING and REPLACING Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy15.8.2018 22:37 | Pressemelding
Please replace the release with the following corrected version due to multiple revisions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005602/en/ New Ebola immunotherapy developed by SAB Biotherapeutics uses natural human polyclonal antibodies to combat disease. (Photo: SAB Biotherapeutics) The corrected release reads: EBOLA SUCCESSFULLY NEUTRALIZED BY LATEST GENERATION POLYCLONAL IMMUNOTHERAPY Promising new platform can rapidly respond to emerging infectious diseases Sioux Falls, SD, August 15, 2018 – SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases . The study was conducted at the Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of He
Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy15.8.2018 17:43 | Pressemelding
SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases . The study was conducted by the National Interagency Confederation for Biological Research and other collaborators including United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Naval Medical Research Center (NMRC). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005602/en/ New Ebola immunotherapy developed by SAB Biotherapeutics uses natural human polyclonal antibodies to combat disease. (Photo: SAB Biotherapeutics) According to the World Health Organization, Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans with an average fatality rate around 50%.
Rimini Street Receives Asia-Pacific Stevie Award for Customer Service Innovation15.8.2018 17:05 | Pressemelding
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced it has been honored with a Stevie® Award in the Innovation in Customer Service Management, Planning & Practice category for its ultra-responsive, premium level service in the Asia-Pacific region. This honor marks the Company’s 12th Stevie Award win this year, and the second consecutive year the Company has been recognized by the Asia-Pacific Stevie Awards. Rimini Street recently earned Stevie Awards in several categories, including Company of the Year from the 2018 American Business Awards® and Customer Service Department of the Year from the 2018 Stevie Awards for Sales & Customer Service. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005580/en/ Rimini Street Receives Asia-Pacific Stevie Award for Customer Service Innovat